• Delivered record sales of $1.9 billion with double-digit growth in revenue, EBITDA and EPS
• Reached top-4 brand position in China IMF market, a major milestone
• Launched a range of new products targeting growth opportunities in infant, kids and seniors nutrition

The a2 Milk Company Ltd reported strong FY25 operating and financial performance, with record sales of $1.9 billion, up 13.5% from the prior year. This was driven by double-digit growth in revenue, EBITDA and EPS, as the company executed its growth strategy. Key highlights include reaching a top-4 brand position in the China IMF market, a major milestone in brand health and market penetration, achieving double-digit sales growth and record market share in China label IMF, and launching a range of new products targeting growth opportunities in the infant, kids and seniors nutrition segments, as well as entering the Vietnam IMF market. The company also initiated returns to shareholders, declaring its first ever dividends totalling 20.0 cents per share for FY25. The results were supported by strong operational achievements, including continued growth in China IMF brand health, improved performance in English label IMF, and double-digit growth in the Other Nutritionals segment. The company also made progress on its sustainability initiatives, including reducing Scope 1 and 3 emissions, and advancing its sustainable packaging action plan.

The company is targeting revenue of ~$2.0 billion and EBITDA margins in the 'teens' by FY27, with a focus on driving growth in key markets and categories, improving profitability in the USA and MVM, and transforming its supply chain.

The company remains focused on its growth strategy, with the supply chain transformation a key priority. This includes expanding its China label IMF market access, developing supply capability to enable innovation, and investing in people and planet leadership to drive long-term, sustainable value creation.